The Vall d´Hebron Institute of Oncology (VHIO) Seeks a "Translational Research Technician"
Reference: 2024-59-01
Project reference: PDC2022-133408-I00
Application deadline: 05/11/2024
Number of vacancies: 1
Job description:
The Cancer Cell Cycle Group led by Dr. Marcos Malumbres at Vall Hebron Institute of Oncology (VHIO) is growing. We are looking for exceptional professionals to be part of our Team and to contribute to our project Terapias dirigidas a CDK14-18 en el tratamiento del cáncer.
Our research lab focuses on the basic mechanisms that control cell differentiation and proliferation, and their implications in pathology. We are interested in deciphering the mechanisms that drive tumour cell proliferation, with a patient-focused perspective, and the therapeutic opportunities of inhibiting the activity of critical cell cycle regulators in cancer.
About the role:
We are seeking a qualified and highly motivated individual to join our Research Team as the Translational Research Technician to participate and to provide us support in our multiple translational research projects. The selected candidate will be responsible for collecting, handling, processing, aliquoting and storage of all human and clinical samples (blood, biopsies, tumor samples…) for cellular, biological and molecular studies among others. The selected candidate will be the link between our partner hospitals and our research laboratory.
Responsibilities: Collection, management and storage of patient samples (blood and tissue samples) from different studiesProcessing human samples for cellular, biological and molecular studiesMaintenance of a biological sample databaseCarry out and coordinate the logistics of receiving and sending human samplesPrepare reports on tasks performedParticipate in internal scientific meetings and with other research labs or pharma companies Requirements: FP (Formación Profesional) or Degree in life sciences or similarFluency in English, spoken and written is requiredStrong experience in human sample handling and processingExperience of at least 6 months in projects involving cancer genomicsExperience in at least some of the following techniques: preparation of DNA libraries, WES/WGS, RNAseq, single-cell RNAseq/ATACseq, methylome, CHIP or CUT & RUN, etc.A highly organized, pro-active and detail-oriented individualCapacity to work in teams Additional information: What we offer: The possibility of developing your professional career in a competitive environment.To be part of a centre that is constantly developing, pursuing excellence in research and collaborating with leading teams.We offer and promote a diverse and inclusive environment, and welcome all people equally, regardless of age, disability, gender, nationality, race, religion or sexual orientation.Working conditions: Salary will be estimated according to profile and experience, funded by public funds (Proyecto de Prueba de Concepto, anualidad 2022).Flexible working hours and measures to reconcile work, family, personal life and gender equality, as stipulated in the VHIO agreement.Flexible remuneration programme (including restaurant vouchers, medical insurance, transport and childcare vouchers).23 days of holiday and 5 days of free disposal. Applications:
Potential candidates should submit a curriculum vitae and a letter of intent via email to ****** including the reference "Ref. 2024-59-01" in the subject line of their email. Review of applications will commence immediately; interviews will be arranged with short-listed candidates.
About VHIO:
Under the leadership of Josep Tabernero, the Vall d'Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d'Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d'Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO's translation toward precision oncology: http://www.vhio.net
#J-18808-Ljbffr
